PARP14 high expression in human primary pancreatic cancer (PCa) is associated with poor prognosis, and PARP14 promotes the proliferation and gemcitabine chemoresistance of pancreatic cancer cells through activation of NF-κ pathway [17]. Here, PARP14 is linked to pancreatic neoplasm.